New Member Joins CQDM’s Board of Directors: A Strategic Health Innovation Expert
CQDM is proud to welcome Stephanie Michaud to its Board of Directors.
A close partner of the organization since its early days, she brings in-depth knowledge of our mission, activities, and evolution.
A recognized expert in health innovation and innovation policy, Stéphanie is a leading voice in Canada’s life sciences ecosystem. Her sharp understanding of national issues and strategic vision are major assets for CQDM.
Her appointment marks a new chapter in our governance, fully aligned with our ambition to foster impactful scientific and economic outcomes across Canada.
Our Sincere Thanks to Louise Proulx for Her Remarkable Commitment
We extend our heartfelt thanks to Louise, who is stepping down from the Board after years of dedicated service.
Throughout her tenure, she played a key role in shaping CQDM’s major milestones, drawing on a rich background spanning academic research and the pharmaceutical industry.
Her involvement has left a lasting mark on Quebec’s life sciences sector, which she helped structure and elevate on the national stage.
A Natural and Promising Transition
This transition reflects a continuity of vision. Diane Gosselin is passing the torch to Véronique Dugas, who will carry forward our shared mission with energy and ambition: to support collaborative health innovation that improves patient outcomes.
👉 To learn more about our Board members and their areas of expertise, visit our Governance page: /about/governance/
